Low Grade Glioma of Brain, Multiple Sclerosis, Sexual Dysfunctions
Conditions
Brief summary
This study aim to ensure that the implementation of a paramedical screening program and counseling in sexual health of patients with neurological pathologies (low-grade gliomas and Multiple Sclerosis) improves their sexual health.
Interventions
OTHERParamedical care
Paramedical early detection of sexual dysfunction and sexual health counseling
Sponsors
Assistance Publique - Hôpitaux de Paris
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Any major patient, followed in the GHPSCF (Groupe Hospitalier Pitié-Salpêtrière Charles Foix) neurology department 2 for a diagnosis of low grade glioma or anaplastic glioma with loss 1p / 19q sub-reserve histo-molecular confirmation after national reading (POLA) and presenting: * An MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire) questionnaire with at least one of the items rated 4 or 5 and * A HAD (Hospital Anxiety and Depression) questionnaire (depression component) with a score ≤ 11 2. Any major patient with MS(Multiple Sclerosis), followed in the GHPSCF Department of Neurology: * With an EDSS (Expanded Disability Status Scale) greater than or equal to 1 and * An MSISQ15 questionnaire with at least one of the items rated 4 or 5. * A HAD questionnaire (depression component) with a score ≤ 11 3. Signature of informed consent 4. Patient affiliated to a social security system
Exclusion criteria
1. Minor patients 2. Pregnant women 3. Patients who do not understand and / or speak French and / or are unable to sign consent 4. Patients with neurological impairment 5. Patients with chronic sexual disorders who have already received treatment. 6. Patients with a HAD score (depression component) greater than 11 7. Patients with MS who had a corticosteroid-treated outbreak in the last two months. 8. Patients with low-grade glioma with clinical and / or radiological scalability during the last three months 9. Any patient whose alteration of the general state would not allow to follow the program. 10. Patients under legal protection For patient's partners: Inclusion criteria: 1. Any patient partner, whose patient has wished to participate and who has accepted. 2. Signing of informed consent Non-Inclusion Criteria: 1. Minor partners 2. Pregnant women 3. Any person who does not understand and / or speak French and / or is unable to sign the consent 4. Partners under legal protection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire) | Inclusion and 3 months | Change of MSISQ15 sexual dysfunctional items at 3-months from baseline |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of HAD scale (Hospital Anxiety and Depression) | Inclusion and 3 months | Change of HAD scale score at 3-months from baseline |
| Change of Rosenberg's Self-esteem Scale | Inclusion and 3 months | Change of Rosenberg's Self-esteem Scale score at 3-months from baseline |
| Change of Quality of life scale | Inclusion and 3 months | Change of Quality of life scale score at 3-months from baseline |
| Change of MSISQ15 (Multiple Sclerosis Intimacy and Sexuality Questionnaire) | Inclusion and 6-months | Change of MSISQ15 sexual dysfunctional items at 6-months from baseline |
| Change of SEP59 scale (Sclérose En Plaques) | Inclusion and 3 months | Change of SEP59 scale score at 3-months from baseline |
| Program satisfaction scale | 3 months | Program satisfaction scale scores at 3-months |
| Change of QLQ-C30/BM20 scale (Quality of Life Questionnaire - Core Questionnaire / Brain Module) | Inclusion and 3 months | Change of QLQC30/BM20 score at 3-months from baseline |
Countries
France
Outcome results
None listed